John M. Luk
Hong Kong Science Park
Sha Tin, NST, Hong Kong Special Administrative Region
Sha Tin, NST, Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 21, 2017
Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
Journal: Oncotarget
Published: August 01, 2016
SOD2 rs4880 CT/CC genotype predicts poor survival for Chinese gastric cancer patients received platinum and fluorouracil based adjuvant chemotherapy.
Journal: American journal of translational research
Published: November 01, 2014
Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2.
Journal: Digestive diseases and sciences
Published: January 03, 2014
Diverse modes of genomic alteration in hepatocellular carcinoma.
Journal: Genome biology
Published: November 06, 2013
Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo.
Journal: Molecular cancer
Published: August 15, 2013
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.
Journal: Genome research
Published: June 22, 2013
miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
Journal: PloS one
Published: June 17, 2013
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Journal: The New England journal of medicine
Published: June 14, 2013
Circulating markers for prognosis of hepatocellular carcinoma.
Journal: Expert opinion on medical diagnostics
Published: May 07, 2013
Last Updated: 09/26/2026